| Product NDC: | 10019-651 | 
| Proprietary Name: | Sevoflurane | 
| Non Proprietary Name: | Sevoflurane | 
| Active Ingredient(s): | 250 mL/250mL & nbsp; Sevoflurane | 
| Administration Route(s): | RESPIRATORY (INHALATION) | 
| Dosage Form(s): | LIQUID | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 10019-651 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075895 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20111018 | 
| Package NDC: | 10019-651-64 | 
| Package Description: | 6 BOTTLE in 1 CARTON (10019-651-64) > 250 mL in 1 BOTTLE | 
| NDC Code | 10019-651-64 | 
| Proprietary Name | Sevoflurane | 
| Package Description | 6 BOTTLE in 1 CARTON (10019-651-64) > 250 mL in 1 BOTTLE | 
| Product NDC | 10019-651 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Sevoflurane | 
| Dosage Form Name | LIQUID | 
| Route Name | RESPIRATORY (INHALATION) | 
| Start Marketing Date | 20111018 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | SEVOFLURANE | 
| Strength Number | 250 | 
| Strength Unit | mL/250mL | 
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |